(Q33976440)

30 July 2017

title

Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice (English)

1 reference

30 July 2017

Vernon W Dolinsky

1

1 reference

30 July 2017

Kyle J Rogan

2

1 reference

30 July 2017

Miranda M Sung

3

1 reference

30 July 2017

Beshay N Zordoky

4

1 reference

30 July 2017

Mark J Haykowsky

5

1 reference

30 July 2017

Martin E Young

6

1 reference

30 July 2017

Lee W Jones

7

1 reference

30 July 2017

Jason R B Dyck

8

1 reference

30 July 2017

language of work or name

1 reference

21 May 2013

1 reference

American Journal of Physiology - Endocrinology and Metabolism

30 July 2017

published in

1 reference

30 July 2017

volume

305

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

E243-53

1 reference

Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Calorie restriction and resveratrol in cardiovascular health and disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Chemosensitization of tumors by resveratrol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Mitochondrial fusion and division: Regulation and role in cell viability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Exercise-induced cardioprotection--biochemical, morphological and functional evidence in whole tissue and isolated mitochondria.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Cardioprotective interventions for cancer patients receiving anthracyclines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

The anthracyclines: will we ever find a better doxorubicin?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Risk factors for doxorubicin-induced congestive heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116416

Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity

5 July 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Natural history of asymptomatic left ventricular systolic dysfunction in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Acute exercise protects against doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Transcriptional analysis of doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00044.2013

Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

21 January 2018

1 reference

12 December 2020

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

12 December 2020

Exercise preconditioning provides long-term protection against early chronic doxorubicin cardiotoxicity

1 reference

12 December 2020

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53

1 reference

12 December 2020

Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats

1 reference

12 December 2020

10.1152/AJPENDO.00044.2013

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference